Anadi Algo News

dr charit bhograj people page on Anadi Algo News

People Landing|80 matching stories

dr charit bhograj News, Mentions & Market Context

AI-analyzed market coverage and mentions for dr charit bhograj, including related stories and trading context.

What Traders Do Next

A market theme is more useful with a process around it.

Use these pages to understand the story first. The clarity usually comes later, after the idea is filtered, tested, and put in context.

Translate It into Rules

See how a market theme can turn into a structured workflow instead of impulse.

Check the Setup

Use a validation step before any trade decision starts feeling obvious.

Read the Main Algo Guide

Start broad if you want to understand the workflow before you optimize the setup.

Here whenever you want to go deeper, never a nudge.Explore Anadi
Top Story|Mintabout 12 hours ago

Tata Trusts files response to Venu Srinivasan, Vijay Singh's complaints before Maharashtra Charity Commissioner

Governance issues in large conglomerates can create uncertainty. No direct operational impact yet.

Neutral
Neutral+2080%
Metals
+20

Impact Score

Affected Stocks

TATASTEELTata Steel
Mixed
TCSTata Consultancy Services
Mixed
TATAMOTORSTata Motors
Mixed
Maintain neutral stance on Tata Group stocks.
Mint3 days ago

Top 3 stocks to buy: Bajaj Finance, Dr Reddy's Lab, Grasim Industries by Sumeet Bagadia | Target price, stop-loss

Nifty prediction: Sumeet Bagadia believes the Nifty 50 RSI has improved to 52.81, well above its average of 34.70, indicating strengthening bullish momentum

Neutral
Economic Times4 days ago

Dr Doom, who predicted global financial crisis, has a forecast for India

The broader market sentiment for India remains cautiously optimistic, with recent rallies despite global cues (NDTV, Oct 15). This expert endorsement adds to the positive narrative, potentially counteracting short-term profit-booking seen today (ETV Bharat, Oct 16).

Bullish+35.785%
5 facts
Maintain a long-term bullish bias on Indian equities, particularly in sectors poised to benefit from global supply chain shifts and domestic consumption growth, with disciplined risk management.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS neutral (+1.6% 1d).
Mint4 days ago

Mistry contends SRTT is delaying reply; trust cites charity commissioner’s order

Corporate governance issues, even within trusts, can impact investor perception of associated listed entities. Transparency is key.

Bearish-5.670%
5 facts
Neutral; no direct trading implications unless the dispute escalates significantly.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS neutral (+1.6% 1d).

Latest dr charit bhograj Mentions

Mint4 days ago+9.9

Tata Trusts challenges Mehli Mistry’s right to contest trustee changes, cites expiry of tenure: Report

Neutral5 factsTATACHEMTCSTATAMOTORS
Mint6 days ago-39.3

Noel Tata, son Neville file caveat against SDTT trustees amid Tata Trusts dispute: Report

Bearish5 factsTCSTATAMOTORSTATASTEELAuto
Bearish bias for Tata Group stocks.|Quick check: TCS bearish bias (-2.1% 1d), TATAMOTORS bearish bias (+1.6% 1d).
Mint7 days ago-36.5

Tata Sons row: Tata Trusts gets more time to respond to 'interference' claims | What Venu Srinivasan, Vijay Singh allege

Bearish5 factsTATASTEELTCSTATAMOTORSMetals
Maintain a neutral to cautious stance on Tata Group stocks, watching for clarity on governance issues.|Quick check: TATASTEEL bearish bias (-0.7% 1d), TCS bearish bias (-2.1% 1d).
Mint7 days ago+16.8

Mehli Mistry rules out reinstatement as Tata Trusts trustee, seeks final order on complaints: Report

4 factsBroad Market
Neutral for now; no direct trading action based on this news.|Quick check: NIFTY bullish bias (overbought), BANKNIFTY neutral (+39.0% 1d).
Economic Times7 days ago-5.6

We have invested $16 billion in R&D of less harmful alternatives for smokers: Philip Morris International’s Tomoko Iida

5 factsTobacco
Maintain a neutral to cautious bias on Indian tobacco stocks like ITC, considering the evolving global landscape and potential future R&D costs for product diversification.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS bearish bias (+1.6% 1d).
Mint7 days ago-1.8

Sir Dorabji Tata Trust gets a week more to respond to complaints by two trustees

Bearish5 factsTCSTATAMOTORSTATASTEELConglomeratesIT Services
Maintain a neutral to slightly cautious bias on Tata Group stocks; focus on fundamental performance and broader market trends, with an eye on any significant escalation of this governance issue.|Quick check: TCS bearish bias (-2.1% 1d), TATAMOTORS bearish bias (+1.6% 1d).
Economic Times8 days ago-67.8

Market wrap: ITC, Apollo Hospital, Dr Reddy's Labs, Bajaj Auto top gainers and losers on Nifty and Sensex on Monday

Bearish5 factsITCAPOLLOHOSPDRREDDYFMCGAutomobile
Quick check: ITC bearish bias (-3.3% 1d), APOLLOHOSP bearish bias (oversold).
Economic Times9 days ago+24.1

Tricog Health targets 100 million cardiac screenings by 2030: CEO Dr Charit Bhograj

5 factsAuto
Maintain a positive bias on healthtech and diagnostic stocks.|Quick check: MARUTI bearish bias (oversold), TATAMOTORS neutral (oversold).
Economic Times11 days ago-32.9

FSSAI pulls up Dr Reddy's, Nestle Health Science over Celevida claims

Bullish5 factsDRLNESTLEINDPharma
Bearish bias for DRL and NESTLEIND; increased regulatory risk.|Quick check: DRL bullish bias (overbought), NESTLEIND neutral (+1.6% 1d).
Economic Times11 days ago-29.1

FSSAI issues notices to Dr Reddy's, Nestle Health Science, Amazon, Flipkart over misleading protein claims

Bullish5 factsDRLNESTLEINDFMCGPharma
Negative bias for companies facing FSSAI notices.|Quick check: DRL bullish bias (overbought), NESTLEIND neutral (+1.6% 1d).
Mint12 days ago+23

Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price

Neutral5 factsACUTAASMANKINDIPCALABPharma
Mixed; bullish on InCred's picks, cautious on those facing pressure.|Quick check: ACUTAAS bullish bias (+3.3% 1d), MANKIND neutral (+0.1% 1d).
Economic Times12 days ago+17.5

Dr Reddys Share Price Live Updates: Dr. Reddy's Shares Slide Under 20-Day EMA

Bullish3 factsDRLBroad Market
Economic Times14 days ago+38.2

Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbath

Bullish5 factsKOTAKBANKDRLBankingPharmaceuticals
Quick check: KOTAKBANK neutral (-0.6% 1d), DRL bullish bias (overbought).
Mint14 days ago+13

Charity commissioner seeks reply from Tata Trusts over trustees’ complaints

5 factsConglomerates
Maintain a neutral stance on Tata Group stocks based on this news alone; focus on company-specific fundamentals and broader market trends.|Quick check: NIFTY bullish bias (+134.1% 1d), SENSEX neutral (+0.5% 1d).
Mint19 days ago+24.8

Noel and son move to shield Trusts as Tata Sons tussle heats up

Bearish5 factsTATASTEELTCSTATAMOTORSAuto
Mint19 days ago-6.7

From software to 17,000 students: How Akhil Shahani built an employability business through peer learning

3 factsIT
Quick check: TCS bearish bias (+0.6% 1d), INFY bearish bias (+0.8% 1d).
Mint20 days ago-61.3

Tata Sons merger proposal faces questions from Tata Trusts trustees: Report

Bearish5 factsTATACHEMTCSTATAMOTORSConglomeratesHolding Companies
For Tata Motors, this news adds a layer of uncertainty. Traders should maintain a cautious stance, watching for any spillover effects from the parent company's issues.|Quick check: TATACHEM bearish bias (-4.3% 1d), TCS bearish bias (oversold).
Economic Times21 days ago+38.8

India Mobile Congress 2026 launches 'Viksit Tech 47' platform to build Indian technology brands for global markets

Bearish5 factsTECHMLTTSInformation TechnologyElectronics Manufacturing Services
Mint21 days ago+55.4

Top stocks to buy for short term: M&M, Engineers India and 1 other by Master Capital Services - Target price, stop loss

Bullish5 factsENGINERSINDRLAutomobilesEngineering
For pharma, consider long positions in DRL, focusing on regulatory updates and pipeline news for confirmation, with strict risk management.|Quick check: ENGINERSIN bullish bias (-0.2% 1d), DRL bullish bias (overbought).
Economic Times22 days ago-53.8

Market wrap: Infosys, Dr Reddy's Labs, Tata Motors PV, Power Grid top gainers and losers on Nifty and Sensex on Monday

Neutral5 factsINFYDRLTATAMOTORSInformation TechnologyPharmaceuticals
Maintain a bearish bias on PSU banks.|Quick check: INFY bearish bias (oversold), DRL bullish bias (overbought).
Mint22 days ago+49.2

Dr Lal PathLabs adds genomics heft with SN Genelab deal

Neutral5 factsLALPATHLABHealthcareDiagnostics
Quick check: LALPATHLAB neutral (-0.5% 1d), NIFTY neutral (+44.4% 1d).
Economic Times22 days ago+29.4

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows three-month performance decline

Bullish4 factsDRLBroad Market
Economic Times24 days ago+37.7

India needs five-year policy to make precision cancer care afforable, says expert

Bearish5 factsLUPINPharmaceuticalsHealthcare Services
Maintain a bullish bias on Indian pharma and diagnostic stocks with strong oncology presence, focusing on companies with robust R&D and manufacturing capabilities.|Quick check: LUPIN bearish bias (-0.2% 1d), SUNPHARMA bearish bias (+0.0% 1d).
Mint25 days ago+2.5

Top stocks in focus tomorrow: Investors must watch Sterlite Tech, Nykaa, JSW Cement shares on Fri, 25 Sept | Triggers

Neutral5 factsDRLALPATHVEDANTANYKAAHealthcareMetals Mining
Monitor these stocks for news-driven gaps or intraday trends.|Quick check: DRLALPATH neutral, VEDANTA bearish bias (-2.0% 1d).
Economic Times25 days ago+53.9

Dr Lal PathLabs to acquire 70 pc stake in SN Genelab for Rs 168 crore

Bullish5 factsLALPATHLABHealthcareDiagnostics
Maintain a bullish bias on established diagnostics players like Dr Lal PathLabs, focusing on companies with clear growth strategies and successful integration of acquisitions.|Quick check: LALPATHLAB bullish bias (+1.4% 1d), TATASTEEL neutral (-1.4% 1d).
Economic Times27 days ago-5.9

VTU announces honorary D.Sc degrees to three educationists

5 facts
Maintain focus on market-moving news such as FII flows, corporate results, and global cues; this news is irrelevant.|Quick check: NIFTY bearish bias (oversold), SENSEX bullish bias (+0.5% 1d).
Economic Timesabout 1 month ago+56.9

QDENGA dengue vaccine to hit India market in 2027; Dr Reddy’s to sell it

Bullish5 factsDRLPharmaceuticalsHealthcare
Maintain a bullish bias on Dr. Reddy's (DRL) for the long term, considering the strategic importance of this vaccine deal.|Quick check: DRL bullish bias (overbought), NIFTY neutral.
Economic Timesabout 1 month ago+57.7

Dr Reddy's inks pact with Gilead for once-yearly HIV prevention drug lenacapavir

Bullish5 factsDRLPharmaceuticals
Maintain a bullish bias on pharma stocks with strong product development and global market reach.|Quick check: DRL bullish bias (overbought), SUNPHARMA neutral (oversold).
Economic Timesabout 1 month ago+63.3

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

Bullish5 factsDRLAUROPHARMAPharmaceuticals
Maintain a bullish bias on select pharma stocks, particularly DRL and AUROPHARMA, with a focus on long positions and disciplined risk management.|Quick check: DRL bullish bias (overbought), AUROPHARMA neutral (-1.8% 1d).
Economic Timesabout 1 month ago+59.6

Dr. Reddy's launches nivolumab biosimilar in India

Bullish5 factsDRLBroad Market
Bullish outlook for DRL; potential for sustained growth in the oncology segment.|Quick check: DRL bullish bias (overbought), NIFTY neutral.
Economic Timesabout 1 month ago+49

Sebi proposes shorter DR drills, stronger resilience norms for mkt infrastructure institutions

Neutral5 factsNSEFinancial ServicesCapital Markets
Maintain a positive bias on MIIs like BSE and CDSL, with a focus on long-term stability and reduced operational risk.|Quick check: NSE neutral, SENSEX bullish bias (+0.5% 1d).
Mintabout 1 month ago+37.6

Best stocks to Buy: Axis Bank, Dr Reddy’s Labs, Indus Towers - Sumeet Bagadia recommends for Tuesday | Target, stop-loss

Bullish4 factsAXISBANKINDUSTOWERBankingPharmaceuticals
For banking, look for signs of improving asset quality and credit demand; for pharma, focus on specific product pipelines or regulatory approvals. Maintain strict risk management.|Quick check: AXISBANK neutral (+0.4% 1d), INDUSTOWER bullish bias (+4.3% 1d).
Economic Timesabout 1 month ago-51.7

Market wrap: HDFC Bank, Dr Reddys, Hindalco, JSW Steel top gainers and losers on Nifty and Sensex on Friday

Bearish5 factsHDFCBANKHINDALCOJSWSTEELBankingMetals
Quick check: HDFCBANK bullish bias (+2.6% 1d), HINDALCO bearish bias (oversold).
Economic Timesabout 1 month ago+1.3

Mumbai's GSB Seva Mandal gets Rs 703 crore insurance cover for Ganesh festival celebration

3 factsBanking
Quick check: HDFCBANK neutral (+0.9% 1d), ICICIBANK neutral (-0.4% 1d).
Mintabout 2 months ago+4.4

“Unbecoming of trustee”: Tata Trusts comment, says Vijay Singh; Tata Trusts say the charity commissioner said so.

Neutral5 factsTCSTATAMOTORSTATASTEELConglomeratesFinancial Services
Maintain a neutral to slightly cautious bias on Tata Group stocks, focusing on their fundamental performance rather than this specific governance dispute, with strict risk discipline.|Quick check: TCS neutral (-1.1% 1d), TATAMOTORS bearish bias (oversold).
Mintabout 2 months ago+10.8

Tata Trusts seek regulator’s nod to break deadlock in Tata Sons chair selection

Neutral4 factsTATASTEELTCSTATAMOTORSBroad Market
Mintabout 2 months ago+30.5

After the lottery win: why Dr Reddy’s may be doing much more in its laboratories

Neutral5 factsDRLPharma
Mintabout 2 months ago+60.3

Multibagger defence stock Apollo Micro System acquires 34% stake in defence tech company

Neutral5 factsAPOLLODefenceAerospace & Defence
Maintain a bullish bias on defence stocks, particularly those with strong R&D and strategic government alignment, with a focus on long-term growth potential.|Quick check: APOLLO neutral (-1.0% 1d), NIFTY bullish bias (+7.9% 1d).
Mint2 months ago-49.2

With no nominee from Sir Ratan Tata Trust, Tata Sons AGM next week may not happen: Report

Neutral5 factsTCSTATAMOTORSTATASTEELConglomeratesIT Services
Maintain a cautious stance on Tata Group stocks.|Quick check: TCS neutral (-0.5% 1d), TATAMOTORS bearish bias (-4.3% 1d).
Economic Times2 months ago+49.6

Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEO

Bullish5 factsGLANDDRLPharma
Neutral to cautiously optimistic for Gland Pharma; await clarity on new CEO's strategic direction.|Quick check: GLAND bullish bias (overbought), DRL bullish bias (overbought).
Economic Times2 months ago+19.6

Narayana Health, NDB sign pact to share smart hospital expertise

Bearish5 factsNHHealthcareHospitals & Healthcare Services
Maintain a bullish bias on healthcare providers embracing digital transformation.|Quick check: NH bearish bias (oversold), HDFCBANK bearish bias (oversold).
Economic Times2 months ago+22.5

India needs to step up public investment to attract private investments: Working paper by EAC-PM

5 factsBroad MarketAuto
Positive bias for capital goods, infrastructure, and manufacturing sectors.|Quick check: MARUTI bearish bias (-0.9% 1d), TATAMOTORS bearish bias (-1.4% 1d).
Economic Times2 months ago-53.9

Dr Agarwals Health shares fall 7% after Rs 2,065-crore block deal; Hyperion Investments, Claymore likely sellers

Neutral5 factsDRLALHealthcare
Maintain a cautious bias on DRLAL in the immediate term.|Quick check: DRLAL neutral, TATASTEEL neutral (-1.3% 1d).
Mint2 months ago-47.6

Tata Group leadership shake-up? N Chandrasekaran may step down as Tata Sons chair amid tensions with largest shareholder

Neutral5 factsTCSTATAMOTORSTATASTEELInformation TechnologyAutomobiles
Maintain a bearish bias on Tata Group stocks.|Quick check: TCS neutral (+0.4% 1d), TATAMOTORS bullish bias (overbought).
Economic Times3 months ago+66.7

Dr Reddy's Laboratories launches generic Sugammadex injection in the United States

Bullish5 factsDRLPharmaceuticals
Maintain a bullish bias on Dr. Reddy's Laboratories (DRL) following this significant US generic launch, with potential for short-term upside. Risk management should include monitoring broader market sentiment and any regulatory changes in the US.|Quick check: DRL bullish bias (overbought), MARUTI neutral (-0.6% 1d).
Economic Times3 months ago+70.7

Nifty Q1 earnings grow 11% to beat estimate, says Motilal Oswal; picks Bharti Airtel, SBI, ICICI Bank among top bets

Bullish5 factsRELIANCEJSWSTEELICICIBANKBankingFinancial Services
Quick check: RELIANCE bullish bias (+1.2% 1d), JSWSTEEL bullish bias (+0.1% 1d).
Mint3 months ago-20.4

Ratan Tata charity fund received cash, shares, and a loan from Tata Sons, units

Bullish5 factsTATASTEELTCSTATAMOTORSBanking
Adopt a cautious or bearish stance on Tata Group stocks until clarity emerges on the undisclosed transactions and governance concerns are addressed.|Quick check: TATASTEEL bearish bias (-0.9% 1d), TCS bullish bias (overbought).
Economic Times3 months ago+68.3

Dr Lal Path Labs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?

Bullish5 factsLALPATHLABHealthcare
Bullish bias for Dr Lal Path Labs; This news is stale, so the initial reaction has likely occurred.|Quick check: NIFTY bullish bias (+13.3% 1d).
Economic Times3 months ago+62.9

Stocks to buy in 2026 for long term: Dr Lal PathLabs, IDFC First Bank among 5 stocks that could give 10-30% return

Bullish5 factsLALPATHLABIDFCFIRSTBBanking
Bullish for Dr Lal PathLabs.|Quick check: LALPATHLAB bullish bias (overbought), IDFCFIRSTB bullish bias (+4.9% 1d).
Economic Times3 months ago-56.8

Dr Reddy’s shares crash 9% after weak Q1 results. Here’s why these 3 brokerages are bearish

5 factsPharmaceuticals
Maintain a cautious bias on the pharma sector.|Quick check: SUNPHARMA bullish bias (+0.1% 1d), CIPLA bearish bias (-0.7% 1d).
Mint3 months ago-33.5

Probe stalls transfer of Ratan Tata’s Tata Sons shares to his foundations

Neutral5 factsTCSTATAMOTORSTATASTEELConglomerate
Neutral to slightly bearish for Tata Group stocks until the probe is resolved.|Quick check: TCS neutral (-1.4% 1d), TATAMOTORS bearish bias (-0.7% 1d).
Economic Times3 months ago+68.3

Dr Reddy’s aims to resume semaglutide supply by November after API fix

Bullish5 factsDRLPharmaceuticals
Given the positive resolution for DRL, a long bias is warranted, but monitor for any further regulatory hurdles or competitive pressures.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (+0.1% 1d).
Economic Times3 months ago-36.7

Tariff hike by US will only increase drug prices: Dr Reddy's CEO

Bullish5 factsDRLPharma
Maintain a bearish bias on Indian pharma stocks with high US generics exposure, anticipating margin pressure.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (+0.1% 1d).
Mint3 months ago-57.4

Dr Reddy’s reports muted Q1FY27 results, net profit drops 69%

5 factsPharmaceuticals
Negative bias for Dr Reddy's; cautious approach for the broader pharma sector until more clarity emerges.|Quick check: MARUTI neutral (+0.9% 1d), TATAMOTORS bearish bias (-0.7% 1d).
Mint3 months ago+44.9

Q1 results 2026: Eternal to Adani Power among companies to declare Q1 results today; full list here

Bullish4 factsADANIPOWERNESTLEINDADANIGREENBanking
High volatility expected for specific stocks; focus on post-earnings analysis and guidance.|Quick check: ADANIPOWER neutral (+0.1% 1d), NESTLEIND bullish bias (+0.2% 1d).
Mint3 months ago+17.1

Vijay Singh’s future on board of Sir Ratan Tata Trust in doubt as term nears end

Neutral4 factsTATACHEMTCSTATAMOTORSAuto
Neutral; no immediate trading action based on this news for listed Tata companies.|Quick check: TATACHEM bearish bias (-0.9% 1d), TCS bullish bias (overbought).
Economic Times3 months ago+45

Dr Reddy's Foundation soil testing lab set to hit 1-lakh sample mark ahead of 2026 rabi season

Bullish5 factsDRLAgricultureChemicals
Quick check: DRL bullish bias (overbought), TCS bullish bias (overbought).
Mint3 months ago+2.6

Warren Buffett removes Gates Foundation from charity list amid Epstein Files controversy

4 factsBroad Market
Irrelevant for Indian equities.|Quick check: NIFTY neutral, BANKNIFTY neutral (+57.5% 1d).
Economic Times3 months ago+6.2

Jamnabai Narsee International School signs Rs 800 crore Juhu lease deal

5 factsReal EstateEducation
Quick check: MARUTI neutral (+1.1% 1d), TATAMOTORS neutral (+1.7% 1d).
Economic Times3 months ago-32

Dr Reddy's shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?

Bullish5 factsDRLPharmaceuticals
Maintain a cautious bias on DRL; Monitor other pharma stocks for any spillover sentiment.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (overbought).
Economic Times3 months ago-30.7

Dr Reddy’s pauses weight loss drug on quality fears

Bullish5 factsDRLTORNTPHARMPharma
Bearish bias for DRL and affected suppliers.|Quick check: DRL bullish bias (overbought), TORNTPHARM bullish bias (overbought).
Mint3 months ago-35.8

Dr Reddy's delays semaglutide supplies due to API issue

Bullish5 factsDRLPharma
Negative bias for DRL.|Quick check: DRL bullish bias (overbought), SUNPHARMA bullish bias (overbought).
Economic Times3 months ago-40.8

Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concerns

Bullish5 factsDRLPharmaceuticals
Maintain a cautious stance on DRL in the short term, looking for clarity on the supply issue resolution.|Quick check: DRL bullish bias (overbought), SUNPHARMA neutral (-0.8% 1d).
Economic Times3 months ago-47.1

Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies

Bullish5 factsDRLPharmaceuticals
Given the negative news for DRL, a bearish bias is warranted for the stock in the short term.|Quick check: DRL bullish bias (overbought), NIFTY neutral (+33.5% 1d).
Economic Times4 months ago+21.8

Tax department steps up scrutiny of charitable trusts over disclosure mismatches

5 factsAuto
Neutral bias; no direct trading implications for listed stocks.|Quick check: MARUTI bullish bias (overbought), TATAMOTORS bearish bias (-0.5% 1d).
Economic Times4 months ago+44.2

Generics must not be imperiled over data protection: Satish Reddy, Chairman, Dr Reddy's Laboratories

Bullish5 factsDRLSUNPHARMACIPLAPharma
Economic Times4 months ago-3.7

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories experiences high trading volume

Bearish3 factsDRLBroad Market
Observe DRL for technical breakouts/breakdowns, using volume as a potential confirmation signal.|Quick check: DRL neutral, NIFTY bearish bias (-73.6% 1d).
Economic Times4 months ago+43.3

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories achieves 6.16% return in one week

Bullish4 factsDRLAuto
Quick check: DRL neutral, MARUTI bullish bias (+4.1% 1d).
Mint4 months ago+36

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday - 29 June 2026

Bullish4 factsDRLTATACONSUMPharmaceuticalsAutomobiles
For Tata Consumer (FMCG), a buy recommendation suggests potential short-term upside; traders should assess current demand trends and price-volume mix for confirmation.|Quick check: DRL neutral, TATACONSUM bullish bias (+3.2% 1d).
Economic Times4 months ago+51.2

India needs innovation at scale to fulfill ambition of becoming global discovery hub: Dr Reddy's

Bullish5 factsDRLSUNPHARMAPharmaceuticalsHealthcare
Maintain a bullish bias on established Indian pharmaceutical companies with strong R&D pipelines, looking for dips as accumulation opportunities.|Quick check: DRL neutral, SUNPHARMA bullish bias (overbought).
Economic Times4 months ago-2

Dr Reddys Share Price Live Updates: Dr. Reddys Stock Details

2 factsBroad Market
No specific trade setup. DRL's movement will be dictated by broader pharma sector trends and company-specific news.|Quick check: NIFTY bullish bias (+14.2% 1d), BANKNIFTY bearish bias (-18.6% 1d).
Economic Times4 months ago+14.4

El Nino fear pushes farmers in Srikakulam and Vizianagaram towards water-saving paddy methods

Neutral5 factsDRLAgricultureChemicals
Maintain a bullish bias on select power sector stocks, focusing on those with strong fundamentals and growth prospects, while monitoring for any policy shifts or climate-related impacts on energy demand.|Quick check: DRL neutral, RELIANCE neutral (+0.3% 1d).
Economic Times4 months ago+42.9

Chenani-Nashri's two-lane tube tunnel gets green light: Union Minister Jitendra Singh

5 factsInfrastructureConstruction
Maintain a bullish bias on infrastructure stocks, focusing on companies with strong balance sheets and proven execution capabilities in large-scale projects.|Quick check: NIFTY neutral, BANKNIFTY neutral.
Mint4 months ago-23.6

Mehli Mistry flags Noel Tata’s ₹1.42 crore fee from Tata Sons; wants it returned to Tata Trusts

Bearish5 factsTCSTATAMOTORSMetals
Maintain a neutral to cautious stance on Tata Group stocks. Focus on individual company fundamentals, but be aware of potential governance overhang.|Quick check: TCS bearish bias (-1.9% 1d), TATAMOTORS bullish bias (+0.0% 1d).
Economic Times4 months ago+4

Promoter entities sell Rs 153 crore worth shares in Motilal Oswal block deal; HDFC Life picks up stake

Bearish5 factsMOTILALOFSHDFCLIFEFinancial ServicesInsurance
Maintain a neutral to slightly positive bias on quality financial services stocks, focusing on companies with strong fundamentals and growth prospects. Risk discipline is key.|Quick check: MOTILALOFS neutral (+0.0% 1d), HDFCLIFE bearish bias (oversold).
Economic Times5 months ago-15.2

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories weekly performance shows decline

Neutral3 factsDRLBroad Market
Maintain a cautious or bearish bias on DRL in the short term.|Quick check: DRL neutral, NIFTY neutral.
dr charit bhograj News, Mentions & Market Context | Anadi Algo News